Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.3 per 10 shares for the financial year ended 31 December 2025, according to its updated cash dividend announcement released on 23 April 2026.

Shareholder approval is scheduled for 29 May 2026. The stock will trade ex-dividend on 16 June 2026, with the record date set for 17 June 2026. Eligible shareholders will receive payment on 13 July 2026.

For investors holding H-shares, the dividend will be paid in Hong Kong dollars; the exact HKD amount and exchange rate will be disclosed later. Share transfer documents must be lodged with Tricor Investor Services Limited by 16:30 on 17 June 2026 to qualify for the distribution. No book-closure period is required.

Withholding tax on the dividend ranges from 10% to 20% for non-resident enterprise shareholders registered outside the People’s Republic of China.

The announcement carries no information on warrants or convertible securities.